Sustained remissions beyond 4 years with epcoritamab monotherapy: Long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma
Authors
Barbara D’Angelo Månsson
Michael Roost Clausen (ORCID: https://orcid.org/0000-0003-3218-3633)
Tatyana A. Feldman (ORCID: https://orcid.org/0000-0002-4458-2896)
Kim Linton (ORCID: https://orcid.org/0000-0002-3294-1548)
Yasmin H. Karimi (ORCID: https://orcid.org/0000-0003-2648-4448)
Christian Winther Eskelund (ORCID: https://orcid.org/0000-0002-6409-8081)
David Cunningham (ORCID: https://orcid.org/0000-0001-5158-1069)
Sustained remissions beyond 4 years with epcoritamab monotherapy: Long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma
Barbara D’Angelo Månsson, Michael Roost Clausen, Tatyana A. Feldman, Kim Linton et al.
Journal
Blood
Topics
CAR-T cell therapy research
article
Sustained remissions beyond 4 years with epcoritamab monotherapy: Long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma
Barbara D’Angelo Månsson, Michael Roost Clausen, Tatyana A. Feldman, Kim Linton, Yasmin H. Karimi, Christian Winther Eskelund, David Cunningham, Tycel Phillips, Martin Hutchings, Chan Yoon Cheah, Won Seog Kim, Catherine Thieblemont, Hervé Ghesquières, Julie M. Vose, Umar Farooq, Wojciech J. Jurczak, Milan S. Geybels, Pegah Jafarinasabian
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
University of Copenhagen (DK), University of Iowa (US), Nebraska Medical Center (US), Royal Marsden NHS Foundation Trust (GB), The University of Western Australia (AU), University of Michigan (US), Sir Charles Gairdner Hospital (AU), Rigshospitalet (DK), AbbVie (United States) (US), Seoul Medical Center (KR), Vejle Sygehus (DK), Assistance Publique – Hôpitaux de Paris (FR), City of Hope (US), Hôpital Lyon Sud (FR), Michigan Medicine (US), National Institute of Oncology (HU), The Christie NHS Foundation Trust (GB), National Science Centre (PL), Hôpital Saint-Louis (FR), Hackensack Meridian Health (US), Krakow Cardiovascular Research Institute (PL), Bristol-Myers Squibb (South Korea) (KR), Iowa City Public Library (US), Genmab (Denmark) (DK), University of Nebraska Medical Center (US)